Filing metadata

Accession number
0000899243-22-001169
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Jan 06, 2022
Reporting period
Jan 04, 2022
Description
Insider transaction

Explore SEC Filings Hub